Next Article in Journal
Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
Next Article in Special Issue
Effects of Extremely Low Frequency Electromagnetic Fields on Melanogenesis through p-ERK and p-SAPK/JNK Pathways in Human Melanocytes
Previous Article in Journal
Monitoring Autophagy Immunohistochemically and Ultrastructurally during Human Head and Neck Carcinogenesis. Relationship with the DNA Damage Response Pathway
Previous Article in Special Issue
Protocatechuic Acid from Pear Inhibits Melanogenesis in Melanoma Cells
Article

Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression

1
Department of Biomedical Chemistry, College of Biomedical & Health Science, Konkuk University, Chungju 27478, Chungbuk, Korea
2
Department of Food Bioscience, College of Biomedical & Health Science, Konkuk University, Chungju 27478, Chungbuk, Korea
3
Nanotechnology Research Center, Konkuk University, Chungju 27478, Chungbuk, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(9), 1924; https://doi.org/10.3390/ijms18091924
Received: 14 August 2017 / Revised: 31 August 2017 / Accepted: 4 September 2017 / Published: 7 September 2017
(This article belongs to the Special Issue Melanins and Melanogenesis: From Nature to Applications)
N-acetyltransferase 10 (NAT10) has been considered a target for the treatment of human diseases such as cancer and laminopathies; however, its functional role in the biology of melanocytes is questionable. Using a small molecule or small interfering RNA targeting NAT10, we examined the effect of NAT10 inhibition on melanogenesis and melanoma growth in human and mouse melanoma cells. Genetic silencing or chemical inhibition of NAT10 resulted in diminished melanin synthesis through the suppression of melanogenesis-stimulating genes such as those encoding dopachrome tautomerase (DCT) and tyrosinase in B16F10 melanoma cells. In addition, NAT10 inhibition significantly increased cell cycle arrest in S-phase, thereby suppressing the growth and proliferation of malignant melanoma cells in vitro and in vivo. These results demonstrate the potential role of NAT10 in melanogenesis and melanoma growth through the regulation of microphthalmia-associated transcription factor (MITF) expression and provide a promising strategy for the treatment of various skin diseases (melanoma) and pigmentation disorders (chloasma and freckles). View Full-Text
Keywords: NAT10; remodelin; MITF; melanogenesis; melanoma growth NAT10; remodelin; MITF; melanogenesis; melanoma growth
Show Figures

Graphical abstract

MDPI and ACS Style

Oh, T.-I.; Lee, Y.-M.; Lim, B.-O.; Lim, J.-H. Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression. Int. J. Mol. Sci. 2017, 18, 1924. https://doi.org/10.3390/ijms18091924

AMA Style

Oh T-I, Lee Y-M, Lim B-O, Lim J-H. Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression. International Journal of Molecular Sciences. 2017; 18(9):1924. https://doi.org/10.3390/ijms18091924

Chicago/Turabian Style

Oh, Taek-In, Yoon-Mi Lee, Beong-Ou Lim, and Ji-Hong Lim. 2017. "Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression" International Journal of Molecular Sciences 18, no. 9: 1924. https://doi.org/10.3390/ijms18091924

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop